Amyloidosis trials in China
11 of 38 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleNon-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Where
- Beijing, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guiyang, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Shaanxi, Shanghai, Shijiazhuang, Suzhou, Taiyuan, Wuhan, Xiamen
- Age
- 18 years to 130 years
- People
- 1,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06465810 - No phaseTaking peopleA Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
- Where
- Beijing
- People
- 2,000
- Run by
- Peking University First Hospital
See details and how to joinNCT05283993 - No phaseTaking peopleLong-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
- Where
- Beijing
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07654855 - No phaseEnrolling by invitationMultimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis
- Where
- Beijing
- People
- 49
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07103863 - No phaseTaking peopleOverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Wuhan
- People
- 52,121 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06355934 - No phaseTaking peoplePan-Amyloid PET/CT in Various Amyloid-Related Disease
- Where
- Hefei, Qingdao, Tianjin
- Age
- 18 years to 80 years
- People
- 500
- Run by
- Tianjin Medical University
See details and how to joinNCT07130565 - No phaseTaking people[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
- Where
- Hefei, Qingdao, Tianjin
- Age
- 18 years and over
- People
- 25
- Run by
- Tianjin Medical University
See details and how to joinNCT07232459 - No phaseTaking peopleRapid dFLC Response Predict CHR in AL Amyloidosis
- Where
- Beijing, Harbin, Nanjing, Shenyang, Xi’an
- Age
- 18 years to 99 years
- People
- 50
- Run by
- Peking University People's Hospital
See details and how to joinNCT06627309 - No phaseTaking peoplePrecision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
- Where
- Beijing
- People
- 1,000
- Run by
- Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07336394 - No phaseEnrolling by invitationAutologous Stem Cell Transplantation for Patients With AL Amyloidosis
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 500
- Run by
- Nanjing University School of Medicine
See details and how to joinNCT04210791 - No phaseTaking peopleClinical Study for AL-CM
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 400
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04924998